As we previously reported, Sanofi-Aventis U.S. LLC, Genzyme Corporation, and Regeneron Pharmaceuticals, Inc. filed a Declaratory Judgment...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
Litigation
-
-
Sanofi-Aventis U.S. LLC, Genzyme Corporation, and Regeneron Pharmaceuticals, Inc. (collectively “Plaintiffs”) filed a Complaint in the...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Samsung Bioepsis UK Limited (“Samsung”), Biogen Idec Limited (“Biogen”), and Fujifilm Kyowa Kirin Biologic Company Limited...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Genentech’s lawsuit against Amgen has come to a quick (although perhaps temporary) end, with the Court dismissing Genentech’s complaint...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
On February 15, 2017, Genentech filed litigation accusing Amgen of violating the Biologics Price Competition and Innovation Act...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
The Supreme Court has agreed to hear its first biosimilar case interpreting two provisions of the Biologics Price Competition and...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]